Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dysport in Cervical Dystonia
NCT00447772Phase 3Completed
- Sponsor
- Ipsen
- Start
- Oct 2004
- Primary completion
- Feb 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
Phase 3, open-label, single-arm trial of abobotulinumtoxinA in cervical dystonia (CD), sponsored by Ipsen. Primary endpoint: Tsui Rating Scale Total Score (Sitting) at 12 weeks. Started Oct 2004; status: completed.
02
Drugs
abobotulinumtoxinA
03
Conditions
cervical dystonia (CD)
Beyond the preview
Go deeper on NCT00447772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00447772.